Medicine
Cordran 0.05% cream
Cordran 0.05% cream is a prescription medicine containing Flurandrenolide for topical use, marketed by INA Pharmaceutics, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F) with excursions permitted to 15° to 30°C…
Key facts
- Active ingredient (INN)
- Flurandrenolide
- Brand
- Cordran
- Strength
- 0.05%
- Dosage form
- Cream
- Route
- Topical
- Packs
- 1 tube
- Marketing authorisation holder
- INA Pharmaceutics
- Manufacturer
- INA Pharmaceutics
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F) with excursions permitted to 15° to 30°C (59° to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- D07AC07 Flurandrenolide
- HS code (indicative)
- 3004.32Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 7 July 2025
- Identifiers
- RxCUI 197718, 898420DailyMed set ID 39c0d1e6-6816-7ae5-e063-6394a90a592eNDC 74157-180, 74157-130Application NDA012806
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 tube in 1 carton / 120 g in 1 tube | 74157-130-07 | INA Pharmaceutics | 7 July 2025 |
| 1 tube in 1 carton / 60 g in 1 tube | 74157-180-60 | INA Pharmaceutics | 7 July 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 19 March 1963 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Flurandrenolide
Clinical summary
Flurandrenolide is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. It is available as lotion, cream and tape for topical use. MedsAcross supplies Flurandrenolide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about FlurandrenolideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- CORDRAN prescribing information (INA Pharmaceutics) · U.S. National Library of Medicine, DailyMed
Need Cordran 0.05% cream for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.